0001437749-23-009270.txt : 20230404 0001437749-23-009270.hdr.sgml : 20230404 20230404160006 ACCESSION NUMBER: 0001437749-23-009270 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230307 FILED AS OF DATE: 20230404 DATE AS OF CHANGE: 20230404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paula Molina Rene CENTRAL INDEX KEY: 0001890868 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41058 FILM NUMBER: 23797143 MAIL ADDRESS: STREET 1: C/O VAXXINITY, INC. STREET 2: 1717 MAIN ST STE. 3388 CITY: DALLAS STATE: TX ZIP: 75201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxxinity, Inc. CENTRAL INDEX KEY: 0001851657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862083865 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 ODYSSEY WAY CITY: EXPLORATION PARK STATE: FL ZIP: 32953 BUSINESS PHONE: (254) 244-5739 MAIL ADDRESS: STREET 1: 505 ODYSSEY WAY CITY: EXPLORATION PARK STATE: FL ZIP: 32953 4 1 rdgdoc.xml FORM 4 X0407 4 2023-03-07 0001851657 Vaxxinity, Inc. VAXX 0001890868 Paula Molina Rene C/O VAXXINITY, INC. 505 ODYSSEY WAY MERRITT ISLAND FL 32953 1 See Remarks 0 Stock Option (right to buy) 2.29 2023-03-07 4 A 0 116612 0 A 2033-03-07 Class A Common Stock 116612 116612 D The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 48 equal monthly installments beginning on March 7, 2023. General Counsel and Secretary. /s/ Rene Paula Molina 2023-04-03